Pura Vida Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100,000
Closed -$16.2M 205
2022
Q1
$16.2M Buy
+100,000
New +$14.5M 0.53% 45
2021
Q1
Sell
-100,000
Closed -$10.7M 216
2020
Q4
$10.7M Buy
+100,000
New +$9.61M 0.39% 66

Other funds holding ABBV

Pura Vida Investments's ABBV Position: Q4 2022 in Review

Pura Vida Investments sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 50,000 shares — an estimated $6.71M sold.

Pura Vida Investments first reported a position in ABBV in Q2 2015 and held it in 10 quarters. The position peaked at $9.42M in Q4 2016. 3,169 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Pura Vida Investments reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 AbbVie shares in Q4 2022, an estimated $6.71M.
  • Pura Vida Investments first reported a position in AbbVie in Q2 2015 and held it in 10 quarters.
  • Pura Vida Investments's AbbVie position peaked at $9.42M in Q4 2016.
  • 3,169 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.